Press Releases | American Food & Beverage Online

Explore more publications!

Press Releases

Meridian Rapid Defense Group Opens New Central U.S. Operations Hub in Hutto, Texas

2 hours ago

Meridian Rapid Defense Group Opens New Central U.S. Operations Hub in Hutto, Texas

EIN Presswire

$Serenity Medical Receives U.S. FDA HDE Approval of the River™ Stent - the First Venous Stent Approved for Severe, Refractory Idiopathic Intracranial Hypertension (IIH)$

4 hours ago

Serenity Medical Receives U.S. FDA HDE Approval of the River™ Stent - the First Venous Stent Approved for Severe, Refractory Idiopathic Intracranial Hypertension (IIH)

GlobeNewswire, Inc.

i-Lumen Scientific Receives FDA Approval of IDE to Initiate U.S. Enrollment in i-SIGHT2 Clinical Study for dry AMD

5 hours ago

i-Lumen Scientific Receives FDA Approval of IDE to Initiate U.S. Enrollment in i-SIGHT2 Clinical Study for dry AMD

EIN Presswire

Circana Research Reveals U.S. Private Label CPG Sales Reach $330 Billion

6 hours ago

Circana Research Reveals U.S. Private Label CPG Sales Reach $330 Billion

GlobeNewswire, Inc.

Housing Insecurity Emerges as Most Pressing Need Across the U.S., New 211 Data Shows

6 hours ago

Housing Insecurity Emerges as Most Pressing Need Across the U.S., New 211 Data Shows

GlobeNewswire, Inc.

7 hours ago

Ambros Therapeutics Announces Notice of Allowance for New U.S. Patent Application Covering Neridronate for Complex Regional Pain Syndrome Type 1

GlobeNewswire, Inc.

7 hours ago

Nuwellis Pediatric Category Achieves Approximately 50% of Total U.S. Revenue in 2025, Marking Growth Milestone

GlobeNewswire, Inc.

Over $1.75M Raised for OC’s Unhoused Families at Illumination Health + Home’s Chef’s Table Gala

an hour ago

Over $1.75M Raised for OC’s Unhoused Families at Illumination Health + Home’s Chef’s Table Gala

GlobeNewswire, Inc.

8 hours ago

Agios Advances Mitapivat Toward Potential U.S. Accelerated Approval in Sickle Cell Disease Following Pre-sNDA Meeting with FDA

GlobeNewswire, Inc.

7 hours ago

Mama’s Creations to Host Fourth Quarter Fiscal 2026 Earnings Call on April 14 at 4:30 p.m. Eastern Time

GlobeNewswire, Inc.

7 hours ago

GAGE Launches the World’s First Workforce Community Connecting Employees and Employers

EIN Presswire

Global Soft Drink Concentrates Market North America Leads with Coca-Cola & PepsiCo Driving Growth Trends

10 hours ago

Global Soft Drink Concentrates Market North America Leads with Coca-Cola & PepsiCo Driving Growth Trends

EIN Presswire

ISO 9001 Consulting Firms Report U.S. Businesses Leave Money on the Table-$6 Revenue per $1 Spent on Quality Management

Mar. 30, 2026

ISO 9001 Consulting Firms Report U.S. Businesses Leave Money on the Table-$6 Revenue per $1 Spent on Quality Management

EIN Presswire

Largest U.S. Event Dedicated to Food Hall Operations Nears Sellout

Mar. 30, 2026

Largest U.S. Event Dedicated to Food Hall Operations Nears Sellout

EIN Presswire

18 hours ago

American Hotel Income Properties REIT LP Reports Q4 2025 Results, Improved Balance Sheet and Demonstrated Hotel Value

GlobeNewswire, Inc.

U.S. Ambulatory Surgery Center Market Analysis of Size, Shares, Business Growth, and Upcoming Trends Forecast 2026-2033

Mar. 30, 2026

U.S. Ambulatory Surgery Center Market Analysis of Size, Shares, Business Growth, and Upcoming Trends Forecast 2026-2033

EIN Presswire

Ozop Energy Solutions, Inc. Highlights Second NBA Athlete Partnership Through Varon USA’s Joint Venture in Ballislife Drink

Mar. 30, 2026

Ozop Energy Solutions, Inc. Highlights Second NBA Athlete Partnership Through Varon USA’s Joint Venture in Ballislife Drink

GlobeNewswire, Inc.

Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)

Mar. 30, 2026

Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)

GlobeNewswire, Inc.

Mar. 30, 2026

Beyond Oil Expands into U.S. Supermarket Vertical with Multi-Phase Commercial Rollout with a Top-Tier U.S. Supermarket Brand

GlobeNewswire, Inc.

Mar. 30, 2026

Zymeworks Receives U.S. FDA Fast Track Designation for ZW191, an FRα-Targeting Antibody-Drug Conjugate

GlobeNewswire, Inc.